ATC code D01
ATC code D01 Antifungals for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup D01 is part of the anatomical group D Dermatologicals.[4]
ATC codes |
---|
D Dermatologicals |
D01 Antifungals for dermatological use |
D02 Emollients and protectives |
D03 Preparations for treatment of wounds and ulcers |
D04 Antipruritics, including antihistamines, anesthetics, etc. |
D05 Antipsoriatics |
D06 Antibiotics and chemotherapeutics for dermatological use |
D07 Corticosteroids, dermatological preparations |
D08 Antiseptics and disinfectants |
D09 Medicated dressings |
D10 Anti-acne preparations |
D11 Other dermatological preparations |
ATCvet only |
QD51 Products for the treatment of claws and hoofs |
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD01.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
D01A Antifungals for topical use
D01AA Antibiotics
- D01AA01 Nystatin
- D01AA02 Natamycin
- D01AA03 Hachimycin
- D01AA04 Pecilocin
- D01AA06 Mepartricin
- D01AA07 Pyrrolnitrin
- D01AA08 Griseofulvin
- D01AA20 Combinations
D01AC Imidazole and triazole derivatives
- D01AC01 Clotrimazole
- D01AC02 Miconazole
- D01AC03 Econazole
- D01AC04 Clomidazole
- D01AC05 Isoconazole
- D01AC06 Tiabendazole
- D01AC07 Tioconazole
- D01AC08 Ketoconazole
- D01AC09 Sulconazole
- D01AC10 Bifonazole
- D01AC11 Oxiconazole
- D01AC12 Fenticonazole
- D01AC13 Omoconazole
- D01AC14 Sertaconazole
- D01AC15 Fluconazole
- D01AC16 Flutrimazole
- D01AC17 Eberconazole
- D01AC18 Luliconazole
- D01AC19 Efinaconazole
- D01AC20 Imidazoles/triazoles in combination with corticosteroids
- D01AC52 Miconazole, combinations
- D01AC60 Bifonazole, combinations
- QD01AC90 Enilconazole
D01AE Other antifungals for topical use
- D01AE01 Bromochlorosalicylanilide
- D01AE02 Methylrosaniline
- D01AE03 Tribromometacresol
- D01AE04 Undecylenic acid
- D01AE05 Polynoxylin
- D01AE06 2-(4-chlorphenoxy)-ethanol
- D01AE07 Chlorphenesin
- D01AE08 Ticlatone
- D01AE09 Sulbentine
- D01AE10 Ethyl hydroxybenzoate
- D01AE11 Haloprogin
- D01AE12 Salicylic acid
- D01AE13 Selenium sulfide
- D01AE14 Ciclopirox
- D01AE15 Terbinafine
- D01AE16 Amorolfine
- D01AE17 Dimazole
- D01AE18 Tolnaftate
- D01AE19 Tolciclate
- D01AE20 Combinations
- D01AE21 Flucytosine
- D01AE22 Naftifine
- D01AE23 Butenafine
- D01AE24 Tavaborole
- D01AE54 Undecylenic acid, combinations
- QD01AE91 Bronopol
- QD01AE92 Bensuldazic acid
D01B Antifungals for systemic use
D01BA Antifungals for systemic use
- D01BA01 Griseofulvin
- D01BA02 Terbinafine
- D01BA03 Fosravuconazole
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code D01". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QD01". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.